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Objective: Structural and functional abnormalities have been noted in the prefrontal cortex 
of individuals with neurodevelopmental disorders such as attention deficit/hyperactivity 
disorder (ADHD). Cortical thickness and gyrification, both of which have been reported 
as abnormal in the prefrontal cortex in ADHD, are thought to be modulated by genetic 
influences during neural development. This study aimed to investigate the effects of a 
polymorphism of the dopamine DRD4 gene (the 7-repeat (7R) “risk” allele) on thickness 
and gyrification as distinct parameters of prefrontal cortical structure in children with ADHD.
Method: Structural images and genetic samples were obtained from 49 children aged 
9–15 years (25 with ADHD and 24 matched controls), and measures of cortical thickness 
and gyrification for inferior, middle, and superior frontal cortex were calculated.
Results: A significant interaction between diagnosis and genotype on prefrontal gyrification 
was observed, largely driven by reduced inferior frontal gyrification in patients who carried 
the DRD4 7R allele. Furthermore, inferior frontal gyrification—but not thickness—related 
to everyday executive functioning in 7R allele carriers across groups.
Conclusions: Prefrontal gyrification is reduced in children with ADHD who also carry the 
DRD4 7R allele, and it relates to critical functional skills in the executive domain in carriers 
of the risk allele. More broadly, these effects highlight the importance of considering 
precise neurodevelopmental mechanisms through which risk alleles influence cortical 
neurogenesis and migration.
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INTRODUCTION
Attention deficit/hyperactivity disorder (ADHD) is a heterogeneous neuropsychiatric disorder 
characterized by developmentally inappropriate symptoms of inattention, impulsivity, and 
hyperactivity. The disorder is thought to affect around 1–5% of children and is highly heritable, 
with multiple genes of small effect contributing to the clinical phenotype (1). Although a number 
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of genome-wide association studies (GWAS) [e.g., Refs. (2, 3)] 
have failed to show genome-wide significance in ADHD, a recent 
GWAS meta-analysis found associations with ADHD for 12 
independent genome-wide significant loci (4). The dopamine D4 
receptor (DRD4) gene, expressed primarily in limbic regions and 
the prefrontal cortex (PFC) (5), contains a 48-base-pair variable 
number tandem repeat in exon 3. A 7-repeat (7R) allele has 
been identified as a prominent risk allele for ADHD (6–10) and 
produces a blunted response to dopamine (11). At a neurochemical 
level, an abnormality in dopaminergic neurotransmission is well 
established in ADHD (12, 13) in keeping with the therapeutic 
effects of methylphenidate (MPH), an indirect dopamine 
agonist widely used to treat the disorder. ADHD has a strong 
neurodevelopmental basis, with numerous local and global brain 
abnormalities being observed (14) particularly in the cortical 
thickness of the prefrontal regions (15, 16). However, despite 
the convergence of evidence from genetic and pharmacological 
studies implicating the dopaminergic system, the relationship 
between genetic risk factors, dopaminergic imbalances, and the 
neurodevelopmental abnormalities observed in ADHD is most 
likely complex and remains unclear, but can be informed by 
models of genetic influences on cortical development (17, 18).
A bulk of the genetic polymorphisms identified to be associated 
with ADHD in genome-wide studies is functionally related to 
neural development (19). Animal studies have demonstrated a 
relationship between dopaminergic imbalance and alterations in 
cortical neurogenesis (20, 21). Dopamine plays a crucial role in 
the cell cycle of neural progenitors (22) as well as prefrontal cortex 
(PFC) functioning (23) and executive control (24), with the latter 
two heavily implicated in the pathophysiology of ADHD. A series 
of investigations seeking to identify the genetic control of cortical 
development suggest that subtle disturbances in the control of 
neurogenesis and migration can result in abnormalities affecting 
behavior that become apparent only during later postnatal 
life (25). Disturbances in early neurogenesis and neuronal 
migration can affect the process of cortical folding, resulting 
in abnormalities in cortical gyrification (26). Aberrations in 
cortical gyrification have been reported in initial investigations 
in children with ADHD (27, 28) and in longitudinal studies (29) 
though some studies have failed to observe such aberrations (30). 
The normal developmental trajectory of cortical gyrification is 
thought to be influenced by genetic mechanisms that are distinct 
from those controlling cortical volume or thickness (31, 32). 
Thus, cortical gyrification, and specifically its characteristics in 
PFC, is likely to be a potential intermediate phenotype reflecting 
aberrant neurodevelopment in ADHD and one whose mediation 
by dopaminergic imbalances and its genetic modifiers has not 
thus far been investigated.
A large genetic imaging study seeking to identify the mediating 
effect of neuroanatomical deficits in the relationship between 
the DRD4 7R risk allele and ADHD phenotype revealed lateral 
prefrontal thinning in patients with ADHD (33). The observed 
pattern of cortical thinning was comparable to differences 
noted in individuals carrying the 7R risk allele who did not 
have ADHD (33), suggesting that in the presence of risk alleles, 
the morphological abnormalities noted in the PFC of children 
with ADHD may be inflated. In a smaller study, reduced lateral 
prefrontal volume was also observed in patients who carry the risk 
allele (7). Cortical gyrification was not investigated in the above 
studies. Based on these observations (7, 33), we hypothesized 
that the 7R risk allele would be associated with alterations in the 
cortical thickness and gyrification of the PFC seen in ADHD. To 
this end, we investigated the effect of the DRD4 7R allele carrier 
status on both thickness and gyrification of the lateral PFC in 
children with ADHD and healthy controls.
MATERIALS AND METHODS
Participants
Participants were recruited as part of an functional magnetic 
resonance imaging(fMRI)/electroencephalography (EEG) study 
reported elsewhere (34, 35) and described in detail in Batty 
et  al. (16). Briefly, right-handed participants with a Diagnostic 
and Statistical Manual of Mental Disorders, Fourth Edition 
(DSM-IV) clinical diagnosis of ADHD (combined subtype) and 
an established positive response to methlyphenidate (MPH) were 
recruited from child psychiatry and community pediatric clinics 
in Nottinghamshire and Lincolnshire. Controls were recruited 
from primary and secondary schools in the Nottinghamshire 
region and matched for age ( ±6 months), sex, and socioeconomic 
status. Exclusion criteria included presence or history of head 
injury, psychosis, epilepsy, Tourette syndrome, autistic spectrum 
disorder, moderate or severe learning difficulties, or current use 
of non-stimulant or other psychotrophic medication (except 
melatonin). After a complete description of the study, written 
informed consent and verbal assent were obtained from parents 
and children, respectively. The study was approved by local 
Regional Ethics Committee and the Research and Development 
Departments of Nottinghamshire Healthcare NHS Trust and 
Lincolnshire Partnership NHS Foundation Trust.
Neuroimaging data from 54 children were available. A 
quality control inspection assessed images for gross structural 
abnormalities, motion, and other artifacts. Data from five 
subjects (all controls) were not included because of motion 
artifacts. In the final sample, we report data from 49 subjects with 
good quality neuroimaging and genotyping data; 25 subjects 
with ADHD [age (mean ± SD), 12.66 ± 1.78 years] and 24 healthy 
controls (12.93 ± 1.62 years).
Neuropsychological Measures
Neuropsychological measures including IQ and reading ability 
were obtained from all participants as part of a testing battery (see 
Table 1). All parents completed the Behavior Rating Inventory 
of Executive Functioning (BRIEF) (36), a questionnaire of 
everyday behaviors associated with executive functioning. The 
BRIEF comprises 86 questions (e.g., “written work is poorly 
organised”), forming eight subscales (inhibit, shift, emotional 
control, initiate, working memory, plan/organize, organization of 
materials, monitor), which can be summed to generate an overall 
index of executive functioning, the Global Executive Composite 
(GEC) (36). Population-normed T scores (population mean = 50, 
SD = 10) are used to interpret the child’s executive functioning, 
with high scores indicating potential problems.
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Magnetic Resonance Imaging Protocol
T1-weighted (T1W) brain images in the sagittal plane were 
obtained with a Philips Achieva 1.5-T MRI scanner with an 
eight-channel SENSE head coil using a 3D turbo field echo (TFE) 
sequence with the following parameters: 160 contiguous slices; 
TR/TE, 9.9/3.7 ms; matrix size, 256 × 256; voxel size, 1 × 1 × 1 mm. 
Head movement was minimized by the use of foam pads placed 
within the head coil.
Surface Extraction
Surface extraction and cortical parcellation were carried out 
using FreeSurfer version 5.0 (37). The preprocessing was carried 
out according to the description available at http://surfer.nmr.
mgh.harvard.edu/. Briefly, following skull-stripping and intensity 
correction, the gray–white matter (GM/WM) boundary for each 
cortical hemisphere was determined using tissue intensity and 
neighborhood constraints. The resulting surface boundary was 
tessellated to generate multiple vertices across the whole brain 
before inflating. Using a deformable surface algorithm guided by 
the gray–cerebrospinal fluid (CSF) intensity gradient, the resulting 
gray–white interface was expanded to create the pial surface. The 
inflated surface was then morphed into a sphere, followed by 
registration to an average spherical surface for optimal sulcogyral 
alignment. The neuroanatomical parcellations were obtained 
using the Destrieux sulcogyral based atlas, which follows the 
anatomical conventions of Duvernoy (38). Further description 
of this automatic extraction is available at http://surfer.nmr.mgh.
harvard.edu/fswiki/DestrieuxAtlasChanges. The surface area of 
the right and left hemispheres was computed separately from the 
outer gray matter surface (pial surface) and summed up to obtain 
the total cortical surface area. Cortical thickness was measured 
using the method described by Fischl and Dale (39).
Computing Gyrification
Vertex-wise quantification of cortical gyrification was computed 
using Schaer’s Local Gyrification Indices (LGIs) (40) using images 
reconstructed through the FreeSurfer pipeline. This approach has 
been previously employed to quantify gyrification abnormalities in 
localized regions of interest (41, 42). Schaer’s method is a vertex-
wise extension of Zilles’ gyrification index, which gives a ratio of 
the inner folded contour to the outer perimeter of the cortex (43). 
The measure of LGI for each vertex on the pial surface reflects the 
amount of cortex buried in its locality (a value of 1 would indicate a 
flat pial surface). Mean LGI for anatomically meaningful sulcogyral 
regions can be obtained using the automated parcellation 
procedure from the FreeSurfer. For each anatomical region, the 
LGI value reflects a composite measure of the curvature, depth, and 
frequency of sulcal dips in the region (40). Given our hypotheses, 
we computed the LGI of the three lateral prefrontal sulcogyral 
divisions—superior frontal (composed of superior frontal sulcus 
and gyrus), middle frontal (composed of middle frontal sulcus 
and gyrus), and inferior frontal (including pars orbitalis, pars 
opercularis, and pars triangularis of inferior frontal gyrus along 
with the inferior frontal sulcus) as shown in Figure 1.
Genetic Methods
Samples for genotyping were collected from participants using an 
Isohelix buccal swab (Web Scientific) or a mouthwash solution 
(10 µl 0.9% saline filter sterilized by 0.2 µl filter; Acrodisc Syringe 
filters) depending on subject preference. Samples were always 
collected following an abstinence from food and drink of at least 1 h.
DNA was extracted by centrifugation; 3,000 rpm for 10 min at 
4°C. Pellets were resuspended in 500 µl of 10 mM NaCl/10 mM 
ethylenediaminetetraacetic acid (EDTA) and vortex mixed prior 
to centrifugation at full speed for 1 min. Pellets were resuspended 
in 500 µl of 50 mM NaOH, vortex mixed, and incubated at 100°C 
for 10 min. After centrifugation, 100 ml of 1 M Tris (pH 7.5) was 
added and vortex mixed. A 1:5 dilution of this stock was made 
and used in the PCRs.
The number of 48-bp repeats in each participant was 
determined using PCR across the repeat region. Primers and 
PCR conditions were as described by Nanko et al. (44), except 
that the sense primer was labeled with CY5. PCR products were 
TABLE 1 | Demographic characteristics of the sample.






Gender M = 24 M = 23 0.75 (1)
Age (years) 12.66 (1.78) 12.93 (1.62) 0.45 (47)
Weight (kg) 43.96 (15.50) 51.17 (13.64) 0.09 (47)
Medication 
duration (months)
37.28 (23.71) n/a n/a
Methylphenidate 
dosage (mg/kg/day)
1.07 (.43) n/a n/a
FSIQ 91.36 (11.05) 104.79 (14.48) 0.001 (47)
Digit span scaled 8.12 (3.35) 9.58 (3.34) 0.13 (47)
TOWRE: total 
score
88.96 (21.94) 98.33 (14.96) 0.088 (47)
Conners’ parent 
DSM total score
82.24 (7.52) 43.83 (3.37)  <0.001 (47)
BRIEF 
(parent)-GEC




Higher professional 1 1







ODD 12 0 n/a
CD 6 0 n/a
GAD 4 0 n/a
Specific phobia 4 0 n/a
Reading 1 0 n/a
DCD 1 0 n/a
DRD4 7R carriers 11 7
DRD4 7R 
non-carriers
14 17 0.377 (1)
FSIQ, full scale intelligence quotient; TOWRE, Test of Word Reading Efficiency; 
BRIEF-GEC, Behavior Rating Inventory of Executive Functioning–Global Executive 
Composite; SES, socioeconomic status; ODD, oppositional defiant disorder; 
CD, conduct disorder; GAD, generalized anxiety disorder; DCD, developmental 
coordination disorder; df, degree of freedom.
Some participants had more than one comorbidity.
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electrophoresed on a Beckman CEQ8000 Genetic Analyzer, and 
the number of repeats was determined by size.
Statistical Analysis
All statistical analyses were conducted using SPSS v.25 (IBM 
Inc). Demographic and clinical characteristics were compared 
using two-tailed t tests for continuous variables or chi-square 
(χ2) tests for categorical variables between patients and controls 
(CTRL) as well as between DRD4 7R carriers and non-carriers. A 
significance level of p < 0.05 was used for all tests.
Prefrontal gyrification was analyzed using a repeated-
measures analysis of covariance (ANCOVA) with HEMISPHERE 
(left, right) and REGION (superior frontal, middle frontal, 
inferior frontal) as within-subject factors, DIAGNOSIS (ADHD 
vs. CTRL) and GENOTYPE [7R carriers or non-carriers, in line 
with Monuteaux et al. (7)] as between-subject factors, and total 
brain surface area (global covariate), age, and full scale intelligence 
quotient (FSIQ) as nuisance covariates. LGI covaries with total 
brain surface area (45) as well as IQ (46). At a population level, 
IQ (47) and total surface area are shown to be different between 
children with ADHD and those without ADHD (48, 49). To adjust 
for the possible confound of total surface area on prefrontal LGI, 
we used area as a covariate in line with prior studies (30, 50, 51). 
We assessed the main effects of DIAGNOSIS and GENOTYPE as 
well as the interaction effects in the model. A similar repeated-
measures ANCOVA was used to investigate prefrontal thickness 
separately, with global cortical thickness as the global covariate 
and age and FSIQ as nuisance covariates. For this model, we 
included AGE as a covariate, in line with the recommendation by 
(52). In addition, we used global thickness as a covariate as global 
thickness scales with regional thickness values (53) and global 
thickness has been shown to be reduced in ADHD (15, 33). This 
approach is in line with prior MRI-based thickness studies that 
compare patients and controls (29, Palaniyappan et al., 2012). As 
the two global covariates (total surface area and global thickness) 
had a significant effect on the respective models, to ensure that 
our primary results (DIAGNOSIS × GENOTYPE) do not hinge 
on the inclusion of global covariates, we repeated the analyses 
after excluding the global covariates from the models. For all 
repeated-measures ANCOVA models, where the assumption 
of normality of residuals and/or homogeneity of variance was 
violated, p values for any follow-up tests were calculated from 
bootstrapped 95% confidence intervals for the parameter 
estimates (5,000 samples; bias-corrected and accelerated). Where 
the assumption of sphericity was violated, degrees of freedom 
were adjusted using the Huynh–Feldt correction.
Post hoc ANCOVAs were performed in carriers and non-
carriers separately where a diagnosis × genotype interaction was 
found. Furthermore, percentage changes were calculated for each 
of the three frontal regions separately to identify the magnitude of 
group differences. Statistical power for ANCOVA was estimated 
with G*Power 3.1.3 (54). For main effects of DIAGNOSIS, 
GENOTYPE, and their interaction, our power to detect a large 
effect was 75.7%. We were therefore only adequately powered to 
detect large effect sizes, consistent with the effect sizes reported 
by Monuteaux (7) and Shaw (33), but we nonetheless highlight 
caution in interpreting null effects.
To understand the functional implications of the frontal 
gyrification in carriers and non-carriers, we performed 
correlations of the LGI (mean from both hemispheres for 
each region) to the BRIEF GEC score in carriers and non-
carriers of the 7R allele. Given that there was no Diagnosis × 
Region interaction (see the section Results), correlations were 
performed in the entire sample not just in ADHD subjects. To 
reduce the probability of Type I error, a corrected p value of.008 
(.05/6) was used.
RESULTS
Participant Characteristics: There were no significant difference 
in age, gender, or parental socioeconomic status (SES) between 
children with ADHD and controls (see Table 1).
FIGURE 1 | Regions included in the analysis. The top row shows lateral, medial, and anterior surfaces of the right hemisphere. The bottom row shows lateral, 
medial, and anterior surfaces of the left hemisphere. Labels are displayed on an average reconstructed FreeSurfer pial surface.
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Genotyping: There were no significant differences in 
prevalence of the DRD4 7R allele between children with ADHD 
and controls (p = 0.377; see Table 1).
The results of the analysis of covariance (ANCOVA) for 
cortical thickness and gyrification measures are shown in Table 2.
Cortical Thickness: For prefrontal thickness, there was a 
significant main effect of DIAGNOSIS, whereby the ADHD 
group had a thinner PFC compared to healthy controls; F(1,42) = 
5.52, p = 0.023 (controls: mean [SD] = 2.836 [0.064] mm; ADHD: 
mean [SD] = 2.794 [0.055] mm). The DIAGNOSIS × GENOTYPE 
interaction was not significant (F = 0.007; p = 0.934). Removing 
the global covariate did not alter the results [DIAGNOSIS: 
F(1,43) = 8.4, p = 0.006; DIAGNOSIS × GENOTYPE: F(1,43) = 
0.31, p = 0.58; see Table 3]. Assumptions of homogeneity and 
normality of the residuals were not violated for these models.
Gyrification: A significant DIAGNOSIS × GENOTYPE 
interaction was observed for the gyrification index; F(1,42) = 
5.45, p = 0.024. This interaction indicated that, while in non-7R 
carriers, mean LGI was slightly lower in the control group than 
in the ADHD group, in the 7R carriers, mean LGI was lower in 
the ADHD group. Removing the global covariate did not alter 
the ANCOVA results [DIAGNOSIS: F(1,43) = 1.37, p = 0.25; 
DIAGNOSIS × GENOTYPE: F(1,43) = 3.15, p = 0.036]. There 
was also a significant DIAGNOSIS × GENOTYPE × REGION 
effect, F(1.2,48.8) = 6.017, p = 0.014.
As the assumption of homogeneity of variance and normality 
of residuals was violated in these models, we tested these 
interactions further using a series of bootstrapped univariate 
factorial ANCOVAs, first with global mean frontal LGI as the 
dependent variable, and then, to test the three-way interaction, 
with mean LGI in each frontal region (inferior, middle, and 
superior frontal cortex) in turn as the dependent variable. For 
the DIAGNOSIS × GENOTYPE interaction, the effect remained 
significant (p = 0.042 for interaction parameter). Results from 
each region in turn indicated that this interaction was largely 
driven by a significant interaction effect in inferior frontal cortex 
(p = 0.019 for the interaction parameter). These data are shown 
graphically in Figure 2 and Table 4.
An analysis of simple main effects (with the global covariates) 
revealed that the observed effects on gyrification were driven by a 
significant difference in the risk carriers, with children with ADHD 
showing a significant reduction in prefrontal gyrification, F(1,15) = 
5.031, p = 0.04 (mean [SD] CTRL = 3.497 [0.275]; ADHD = 3.196 
[0.271]), with no significant effect for the global covariate, F(1,15) = 
3.28, p = 0.09. There was a significant DIAGNOSIS × REGION 
effect, F(1.17,17.5) = 5.43, p = 0.027. As the variances for the 
inferior frontal LGI were not equal between the two groups, we used 
Kruskal–Wallis H test to confirm a significant effect of diagnosis on 
inferior frontal LGI (H = 5.8, p = 0.016) among carriers.
In non-carriers, there was no significant diagnostic effect, 
F(1,28) = 2.28, p = 0.10 (mean [SD] CTRL = 3.236 [0.292]; 
ADHD = 3.414 [0.292]), but a significant effect for the global 
covariate, F(1,28) = 14.1, p = 0.001. There was no significant 
DIAGNOSIS × REGION effect among non-carriers, F(1.09,30.6) = 
2.29, p = 0.14. As the residuals for the inferior frontal region 
were not normally distributed, we used Kruskal–Wallis H test to 
confirm the lack of a significant effect of diagnosis on inferior 
frontal LGI (H = 0.76, p = 0.38) among non-carriers.
We also noted that there was no significant effect of genotype 
among both controls [F(1,21) = 4.1, p = 0.06] and children with 
ADHD [F(1,22) = 2.59, p = 0.12]. Kruskal–Wallis H test was not 
significant among both control subjects (H = 3.51, p = 0.06) and 
children with ADHD (H = 0.76, p = 0.38).
Behavioral Correlates: A significant negative correlation was 
observed among carriers of the risk allele (r = −0.67, df = 17, 
p = 0.002), whereby children with high scores on the BRIEF had 
a lower inferior frontal LGI. Importantly, this correlation was not 
observed among the non-carriers (r = 0.20, df = 30, p = 0.28) 
or in the other regions (superior/middle frontal) in either group. 
We used Fisher’s r-to-Z conversion followed by a t test to assess 
the difference in inferior frontal LGI-BRIEF correlation between 
the two groups. We noted a significant difference (z = −3.15, p = 
0.0015), confirming the genotype-specific relationship between 
real-world executive functioning and inferior frontal gyrification.
TABLE 2 | Influence of attention deficit/hyperactivity disorder (ADHD) and DRD4 
gene on the lateral prefrontal gyrification and thickness in ADHD.
Variable Thickness Gyrification
F df p F df p
Hemisphere 0.94 1,42 0.34 0.001 1,42 0.97
Diagnosis 5.52 1,42 0.02 0.19 1,42 0.57
Genotype 0.19 1,42 0.67 0.18 1,42 0.73
Global covariate 93.24 1,42 <0.001 16.37 1,42 <0.001
Diagnosis × 
Genotype
0.01 1,42 0.93 5.447 1,42 0.024
Diagnosis × 
Hemisphere
0.60 1,42 0.45 0.337 1,42 0.56
Diagnosis × Regions 0.88 2,84 0.42 0.299 2,84 0.43
Diagnosis × 
Genotype × Regions
0.66 1,42 0.52 6.017 2,84 0.004
FSIQ 0.26 1,42 0.62 0.001 1,42 0.97
Age 0.26 1,42 0.61 0.20 1,42 0.66
TABLE 3 | Effect of diagnosis on lateral prefrontal thickness in carriers and non-carriers of DRD4 7R allele.
Region DRD4 Carriers 7R Non-carriers
Controls Patients Controls Patients
Mean LGI (SE) Mean LGI (SE) % change Mean LGI (SE) Mean LGI (SE) % change
Superior frontal 2.911 (0.035) 2.830 (0.028) −2.8% 2.915 (0.024) 2.874 (0.026) −1.4%
Middle frontal 2.640 (0.027) 2.596 (0.021) −1.7% 2.655 (0.019) 2.582 (0.020) −2.7%
Inferior frontal 2.948 (0.034) 2.939 (0.27) −0.3% 2.956 (0.023) 2.928 (0.025) −0.9%
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DISCUSSION
Using structural MRI to investigate the interaction between 
genotype (DRD4) and brain structure in ADHD, we found 
that children with ADHD who are carriers of the 7R allele 
had a significant reduction in frontal gyrification compared to 
typically developing controls with the 7R allele. This reduction 
appears to be largely driven by a hypogyric inferior frontal 
gyrus in children with ADHD who carry the 7R “risk” allele. 
These results support our hypothesis that the DRD4 7R allele 
influences the structure of the PFC in the presence of ADHD. 
Interestingly, there was a trend towards hypergyric inferior 
frontal gyrus among the healthy 7R carriers compared to the 
healthy non-carriers. The diagnosis dependent effect of the risk 
allele on brain structure highlights the polygenetic influences on 
cortical neurogenesis and supports the “multiple genes of small 
effect” model of ADHD (55). This effect might also be mediated 
by the inclusion of only participants with ADHD combined 
subtype and the inclusion of oppositional defiant disorder and 
conduct disorder, present in three quarters of the ADHD sample, 
as studies have shown stronger associations with ADHD and 
DRD4 7R in combined ADHD (10) and ADHD with comorbid 
conduct problems (56).
As expected, and consistent with previous work (33), 
children with ADHD had thinner PFC than matched controls. 
Also consistent with this previous study, genotype did not affect 
cortical thickness differentially more in ADHD cases compared 
to controls. However, we observed an association between 
morphometric changes (gyrification) in the inferior frontal 
cortex and the DRD4 7R allele, and this was specific to ADHD 
cases. Another study investigating morphometric changes 
associated with DRD4 7R did not include inferior frontal cortex 
(7), but did however report a significant reduction in superior 
prefrontal volume in carriers of the risk allele among adults 
with ADHD.
For the first time, our results show that children with 
ADHD—but not controls—have reduced frontal gyrification 
in the presence of the 7R risk allele, and these differences 
emerge predominantly in inferior frontal areas. A prevailing 
notion is that the polymorphisms implicated by genome-
wide association studies of ADHD contribute to cortical 
development (19). It is possible that DRD4 7R influences the 
early phase of corticogenesis, through a hitherto unknown 
FIGURE 2 | Plot showing individual Local Gyrification Index (LGI) values 
by Group and Genotype: In frontal cortex overall (left panel) and for inferior 
frontal cortex (right panel). LGI values are adjusted for age, full scale 
intelligence quotient (FSIQ), and total pial area [covariates used in the analysis 
of covariance (ANCOVA)].
TABLE 4 | Effect of diagnosis on lateral prefrontal gyrification in carriers and non-carriers of DRD4 7R allele.
Region DRD4 Carriers 7R Non-carriers
Controls Patients Controls Patients
Mean LGI (SE) Mean LGI (SE) % change Mean LGI (SE) Mean LGI (SE) % change
Superior frontal 2.448 (0.033) 2.448 (0.026) 0% 2.471 (0.023) 2.491 (0.024) +0.80%
Middle frontal 3.150 (0.049) 3.0442 (0.039) −3.4% 3.101 (0.034) 3.120 (0.037) +0.61%
Inferior frontal 4.853 (0.280) 4.160 (0.224) −14.3% 4.153 (0.195) 4.581 (0.178) +9.4%
LGI, Local Gyrification Index.
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mechanism, resulting in an aberrant neurodevelopmental 
trajectory in those who go on to develop ADHD. In fact, the 
anatomical effect of DRD4 7R on inferior frontal regions 
appear to be more pronounced in earlier than later stages 
of neurodevelopment, as shown by Schweren et al. (57) in 
a volumetric study. Though a causal relationship cannot 
be established from this cross-sectional study, it is worth 
noting that longitudinal structural neuroimaging studies 
investigating cortical thickness support the notion that 
ADHD is associated with delayed prefrontal maturation 
(15). Similarly, other longitudinal studies have also found 
reductions in cortical volume in frontal regions in children and 
young people with ADHD (29), primarily driven by reduced 
surface area rather than reduced cortical thickness. In both 
instances, these differences in frontal regions are likely to be 
driven by atypical neuronal proliferation at an early stage of 
development. A normal increase in inferior frontal cortical 
complexity is noted between ages 6 and 16 years (58), raising 
the possibility that the reduced gyrification observed in the 
risk allele carriers with ADHD might be related to a delay in 
cortical maturation, in keeping with models of maturational 
delay in ADHD (59).
We observed a significant diagnosis × genotype × region 
effect for gyrification, with patients who are risk carriers 
showing a pronounced reduction in the LGI of inferior frontal 
gyrus (IFG). This suggests that the dopaminergic influence on 
the development of IFG in ADHD may be distinct from those 
on other lateral frontal regions. The inferior frontal cortex is 
considered to play an important role in inhibitory control in both 
healthy individuals (60) and children with ADHD (61). Inferior 
frontal gray matter reduction, especially in the right hemisphere, 
is associated with behavioral deficits commonly observed in 
ADHD (62), while damage to right IFG has been associated with 
poor inhibitory control (63). In the present study, there was no 
effect of hemisphere on cortical thickness or gyrification. Given 
our power limitations, these may have been too subtle effects for 
us to detect. Furthermore, while some studies have emphasized 
the importance of right IFG in inhibitory control, evidence 
for lateralization of GM deficits in IFG in ADHD is equivocal 
(16, 64). There is some suggestion that the functional changes 
observed in this region could be specific to ADHD (61) and could 
be modified to some extent by pharmacological manipulations 
(65). Our observations suggest that, among carriers, reduced 
inferior frontal gyrification, but not the gyrification of other 
two frontal regions, is linked to poor real-world executive 
functioning measured using BRIEF. Lack of such correlation in 
non-carriers reaffirms our hypothesis that frontal gyrification 
may mediate the risk conferred by 7R allele. Notably, thickness 
did not relate to behavioral correlates such as BRIEF and other 
neuropsychological measures (16).
Although the current results are strengthened by the 
inclusion of a well-defined clinical sample including only 
patients with DSM-IV combined type ADHD [corresponding 
to International Classification of Diseases, Tenth Revision 
(ICD-10) hyperkinetic disorder] and well-matched controls, 
some limitations must nonetheless be acknowledged. While 
the sample size is similar to or larger than that of many other 
morphometry studies (7, 27, 28, 66), our design was only 
sufficiently powered to detect large-sized effects and was not 
optimized to explore the effects of other variables, such as 
the relationship between symptom severity and gyrification. 
Negative findings, such as the lack of genotype effect on 
gyrification and thickness should be interpreted cautiously 
and would benefit from further investigation in larger samples. 
In addition, investigating the extent to which gyrification 
is influenced solely by ADHD or comorbid disorders or an 
interaction of the two requires greater power. Moreover, while 
reductions in gyrification in children with ADHD have been 
demonstrated by some groups (28, 29), others [e.g., Ref. (30)] 
have found no group differences in local gyrification. While 
the inclusion of only combined type ADHD and an almost 
entirely male sample reduce heterogeneity, the extent to which 
the findings can be generalized to other ADHD subtypes 
and to girls with ADHD is unclear, particularly given the 
differential effects of DRD4 with ADHD subtype (10). Finally, 
patients with ADHD were entered onto the study on the basis 
of their current use of and established positive response to 
methylphenidate (MPH), an indirect dopamine agonist. The 
extent to which MPH might influence gyrification, particularly 
in those with the 7R “risk” allele would require the inclusion 
of a medication-naive sample. However, it is unlikely that the 
reduction in frontal gyrification would be mediated by MPH 
for two reasons. Firstly, gyrification begins during the early 
stages of intrauterine life, from around 16 weeks (67) and is 
largely completed during early postnatal development, prior 
to the onset of stimulant medication. Secondly, structural 
abnormalities in children taking medication for ADHD are 
typically reduced relative to non-medicated children with the 
disorder (68, 69). Thus, the structural aberrations observed 
in this sample of medicated patients are more likely to be an 
underestimate of the extent of the pathophysiology.
It is important to consider the lack of significant 
association between DRD4 variants and ADHD in the recent 
large genome-wide association study (4), though some of 
the other affected loci (FOXP2, DUSP6) may have a role in 
synaptic dopamine regulation. It is also likely that the DRD4 
polymorphism interacts with other genetic determinants of 
brain development, thus influencing the brain structure in 
ADHD. Larger genome-wide examination of the relationship 
between ADHD-related common variants and gyrification is 
needed to address this issue.
In conclusion, our findings show for the first time that 
reduced prefrontal gyrification is an important variable when 
investigating the ADHD phenotype in the presence of the 
DRD4 7R risk allele. In carriers of the risk allele, it also relates 
to everyday functional skills that are severely affected in 
ADHD. Investigating in detail multiple parameters of cortical 
morphometry can potentially elucidate the complex findings in 
ADHD genetics by revealing how the cortical developmental 
trajectory is modulated by genetic risk factors in the presence of 
the disorder. Uncovering the interaction between dopaminergic 
polymorphisms and cortical neurogenesis and migration 
holds the promise of a fuller understanding of the converging 
etiological influences in ADHD.
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